Ryan McDonald | Authors

Articles

In Transplant-Eligible, Newly Diagnosed MM, KCd Consolidation Proves Noninferior to ASCT

June 08, 2021

In newly diagnosed, transplant-eligible patients with multiple myeloma, carfilzomib consolidation with cyclophosphamide and dexamethasone conferred noninferior results compared to upfront autologous stem cell transplantation.